Nefazodone (brand name Serzone®, which would also be a good brand name for a BDSM nightclub) is an equally good (and maybe better) antidepressant that does not have these side effects. On the other hand, every year, one in every 300,000 people using nefazodone will go into “fulmi...
While there are no known side effects, directly attributed to the Go-Less® ingredient blend, it is advisable to speak with your health care provider before taking any dietary supplement or medication. Caution: AZO Bladder Control should not be used by pregnant or nursing women, or by childre...
AZO Urinary Pain Relief, AZO Urinary Tract Health Support Pack, AZO Cranberry Gummies, AZO Cranberry Caplets, AZO Cranberry Softgels, AZO Test Strips, AZO Yeast Plus, AZO Bladder Control with Go-Less. The
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with...
While there are no known side effects, directly attributed to the Go-Less® ingredient blend, it is advisable to speak with your health care provider before taking any dietary supplement or medication. Caution: AZO Bladder Control should not be used by pregnant or nursing women, or by childre...
However, sphingomyelin, a phospholipid that lacks a glycerol backbone, is commonly found in plasma membranes of the nerve. Instead of a glycerol backbone it contains sphingosine, an amino alcohol with a long unsaturated hydrocarbon chain. A fatty acyl side chain is linked to the amino group ...
just – I don't have a good insight into that Bret. I wish I did, but obviously hard times are going to put more pressure on folks than good times are. I would expect a higher percentage than we've seen over the last five years. But does it go up 10% or does it go up 25%...
Hey, everybody. Good morning. My first question is just around the improvement in transactions or ticket count. I guess that coincides with less average ticket growth. But, Bill, to your point, there really shouldn’t be a lot of elasticity in this business since it’s more need based, ...
we look for bill payers elsewhere in the P&L to be able to go do that. But what we have done over time, and what we will continue to do is, we invest in a very disciplined way in growth, and we are not afraid to de-lever SG&A if we need to, to support that growth, because...
all the new things that we have in-flight give us a lot of confidence that we’ll be able to go do that. So these are not things to Bill’s point where we’re saying — we’re pinning everything on some macro issue or pinning everything on execution, but we control our own desti...